Jade Biosciences develops and aims to commercialize a pipeline of biologic therapies designed to treat diverse medical conditions. Its biologics are engineered protein-based medicines produced through biotechnology that interact with the immune or cellular systems to modify disease processes. It differentiates by leveraging Paragon Therapeutics’ discovery-stage assets to pursue best-in-class biologics with clearer paths to clinic and market through development partnerships and licensing. The company's goal is to address unmet medical needs and improve patient outcomes by delivering high-quality biologic treatments to healthcare providers and patients.
Company Size
51-200
Company Stage
IPO
Headquarters
Waltham, Massachusetts
Founded
2024
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?